1336975-57-5 Usage
General Description
2'-b-C-Methyl-2-aMino-N6,N6-diMethyladenosine is a modified nucleoside that contains a methyl group at the 2'-carbon of the ribose sugar and a methyl group at the N6 position of the adenine base. It is found in transfer RNA (tRNA) and plays a role in regulating the translation of genetic information into proteins. This chemical modification is important for maintaining the stability and function of tRNA, and it has been implicated in regulating various cellular processes, including protein synthesis and gene expression. Research suggests that 2'-b-C-Methyl-2-aMino-N6,N6-diMethyladenosine may also have potential therapeutic applications in the treatment of certain diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 1336975-57-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,6,9,7 and 5 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1336975-57:
(9*1)+(8*3)+(7*3)+(6*6)+(5*9)+(4*7)+(3*5)+(2*5)+(1*7)=195
195 % 10 = 5
So 1336975-57-5 is a valid CAS Registry Number.
1336975-57-5Relevant articles and documents
2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREATMENT
-
Page/Page column 229; 231, (2018/03/28)
The use of described compounds or pharmaceutically acceptable salts or compositions thereof for the treatment of a host infected with an RNA virus other than HCV, or other disorder more fully described herein.
COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS
-
Page/Page column 64, (2012/10/08)
Provided herein are compounds, compositions and methods for the treatment of liver disorders, including HCV infections. In one embodiment, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.
